Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)

Pressemitteilungen

Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:
 
Print

IBt shareholdings information as required under new legislation implementing the Transparency Directive

Regulated Information

IBt shareholdings information as required under new legislation implementing the Transparency Directive

IBt - (Reuters: IBTH.BR - Bloomberg: IBTB BB)
Seneffe, Belgium, September 11 , 2008.

In compliance with the new legislation implementing the Transparency Declaration (Act of 2 May 2007 and Royal Decree of 14 February 2008) IBt shareholdings as of September 1, 2008 were:

I. Total number of voting rights (per class)      
  Ordinary Shares   17.554.354  
  Beneficiary Shares "A"   5.000.000  
  Beneficiary Shares "B"   25.000  
  Total of voting rights   22.579.354  
II. Other securities      
  Convertible Bonds   0  
  Warrants   142.500  
  Shares without voting rights   0  
III. Total Share Capital     10.874.903EUR  
IV. Denominator     22.579.354  
V. Number of securities from which a declaration of crossing threshold must be issued     5%  



IBt BEBIG Group designs, produces and markets worldwide a complete range of radiotherapy implants used in permanent brachytherapy. The group today includes subsidiaries based in Germany, France, UK, Ireland, Spain, and Italy as well as a large number of distributors spread throughout the world.

Any comments or questions should be addressed to:

Contacts François Blondel, CEO
Laurence Goemaere, Investors Relations Manager
Tel: +32 (0)064.520811
E-mail: ir@ibt.be

Website: www.ibt.be

Back